Basket

0558143 - ÚMCH 2023 RIV CH eng J - Journal Article
Studenovský, Martin - Rumlerová, Anna - Kovářová, Jiřina - Dvořáková, Barbora - Sivák, Ladislav - Kostka, Libor - Berdár, Daniel - Etrych, Tomáš - Kovář, Marek
HPMA copolymer mebendazole conjugate allows systemic administration and possesses antitumour activity in vivo.
Pharmaceutics. Roč. 14, č. 6 (2022), č. článku 1201. E-ISSN 1999-4923
R&D Projects: GA ČR(CZ) GA19-05649S; GA MŠMT(CZ) LTAUSA18083
Grant - others:AV ČR(CZ) JSPS-22-01
Program: Bilaterální spolupráce
Institutional support: RVO:61389013 ; RVO:61388971
Keywords : mebendazole * drug delivery * cancer therapy
OECD category: Polymer science; Pharmacology and pharmacy (MBU-M)
Impact factor: 5.4, year: 2022
Method of publishing: Open access
https://www.mdpi.com/1999-4923/14/6/1201
Permanent Link: https://hdl.handle.net/11104/0333076